Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38026 - 38050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	OIP5-AS1	729082	downregulated	entinostat results in decreased expression of OIP5-AS1 mRNA	15q15.1	A21035
Entinostat	Investigational	OLFM1	10439	upregulated	entinostat results in increased expression of OLFM1 mRNA	9q34.3	A21037
Entinostat	Investigational	OLFM3	118427	upregulated	entinostat results in increased expression of OLFM3 mRNA	1p21.1	A21037
Entinostat	Investigational	OLFML1	283298	upregulated	entinostat results in increased expression of OLFML1 mRNA	11p15.4	A21035
Entinostat	Investigational	OLFML2A	169611	upregulated	entinostat results in increased expression of OLFML2A mRNA	9q33.3	A21037 A21035
Entinostat	Investigational	OLFML3	56944	upregulated	entinostat results in increased expression of OLFML3 mRNA	1p13.2	A21037
Entinostat	Investigational	OMA1	115209	upregulated	entinostat results in increased expression of OMA1 mRNA	1p32.2-p32.1	A21037
Entinostat	Investigational	ONECUT2	9480	upregulated	entinostat results in increased expression of ONECUT2 mRNA	18q21.31	A21037
Entinostat	Investigational	OPCML	4978	downregulated	entinostat results in decreased expression of OPCML mRNA	11q25	A21035
Entinostat	Investigational	OPCML	4978	upregulated	entinostat results in increased expression of OPCML mRNA	11q25	A21037
Entinostat	Investigational	OPN3	23596	downregulated	entinostat results in decreased expression of OPN3 mRNA	1q43	A21037
Entinostat	Investigational	OPRK1	4986	downregulated	entinostat results in decreased expression of OPRK1 mRNA	8q11.23	A21035
Entinostat	Investigational	OPTN	10133	upregulated	entinostat results in increased expression of OPTN mRNA	10p13	A21035
Entinostat	Investigational	ORM2	5005	downregulated	entinostat results in decreased expression of ORM2 mRNA	9q32	A21037
Entinostat	Investigational	OSBPL10	114884	upregulated	entinostat results in increased expression of OSBPL10 mRNA	3p23	A21037
Entinostat	Investigational	OTUD7B	56957	downregulated	entinostat results in decreased expression of OTUD7B mRNA	1q21.2	A21037
Entinostat	Investigational	P2RX5	5026	upregulated	entinostat results in increased expression of P2RX5 mRNA	17p13.2	A21037
Entinostat	Investigational	P3H2	55214	upregulated	entinostat results in increased expression of P3H2 mRNA	3q28	A21037
Entinostat	Investigational	P4HA2	8974	upregulated	entinostat results in increased expression of P4HA2 mRNA	5q31.1	A21037 A21035
Entinostat	Investigational	PABPN1	8106	downregulated	entinostat results in decreased expression of PABPN1 mRNA	14q11.2	A21037
Entinostat	Investigational	PACSIN1	29993	upregulated	entinostat results in increased expression of PACSIN1 mRNA	6p21.3	A21035
Entinostat	Investigational	PACSIN3	29763	upregulated	entinostat results in increased expression of PACSIN3 mRNA	11p11.2	A21037
Entinostat	Investigational	PAGE4	9506	upregulated	entinostat results in increased expression of PAGE4 mRNA	Xp11.23	A21037
Entinostat	Investigational	PAH	5053	upregulated	entinostat results in increased expression of PAH mRNA	12q23.2	A21037
Entinostat	Investigational	PAK6	56924	upregulated	entinostat results in increased expression of PAK6 mRNA	15q15.1	A21037

Displaying entries 38026 - 38050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability